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1. Introduction 
Currently, endoscopic resection (ER) is the standard treatment for early gastric cancer 
(EGC), not only in Japan but also in other parts of the world. (Gotoda T et al., 2006) 
A new endoscopic resection procedure, called endoscopic submucosal dissection (ESD), 
allows the direct dissection of the submucosa and has made en bloc resection of large 
intramucosal or ulcerated lesions feasible. However, at present, the indications for use of ER 
are limited to EGC without lymph node metastasis. 
Gotoda et al. studied surgically resected specimens from EGC patients and decided upon 
the following four indication criteria for endoscopic resection of EGC without lymph node 
metastasis. (Gotoda T et al.,2000) (Fig 1)  
1. differentiated intramucosal cancer without ulceration, regardless of size 
2. differentiated intramucosal cancer with ulceration, 30mm or less in size  
3. differentiated minute submucosal penetrative cancer (SM1), 30mm or less in size 
4. undifferentiated intramucosal cancer without ulceration, 20mm or less in size 
 
 
Fig. 1. Extended criteria for endoscopic resection (Tumor size is shown in millimeters).  
EMR: Endoscopic mucosal resecton.  ESD: Endoscopic submucosal dissection. 
UL: ulcerative findings.  SM: submucosal 
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Expansion of the indications for ER to include undifferentiated-type EGC is not widely 
accepted at this time because undifferentiated-type EGC has been associated with higher 
rates of lymph node metastasis than has differentiated-type EGC. (Sano T et al.,1992 ;  
Yamao T et al.,1996)  
Furthermore, it is sometimes difficult to delineate carcinomatous areas in cases where 
undifferentiated-type EGC is not exposed on the mucosa surface. (Ninomiya Y et al.,2000)  
As a result, successful endoscopic resection is reportedly less common in patients with 
undifferentiated-type EGC compared to those with differentiated EGC. (Miyata M et 
al.,2000) To avoid invasive surgery, and thereby optimize the patient’s quality of life, it is 
important to expand the ER indication to include undifferentiated-type EGC in patients at a 
very low risk of lymph node metastasis. 
Recently, several studies for undifferentiated-type EGC treated by endoscopic resection have 
been reported from different institutions. (Kim JH et al., 2009 ; Kang HY et al.,2010 ; Yamamoto 
Y et al.,2010) According to these reports, endoscopic resection for undifferentiated-type EGC 
was technically feasible and might be considered an alternative treatment modality. 
In this review, we described the state of diagnostic and therapeutic endoscopy for 
undifferentiated-type EGC.  
2. Undifferentiated-type EGC without lymph node metastasis 
Because ER involves only local treatment without lymph node dissection, as a rule, it is 
performed only if lymph node metastases are not present.  
In the study by Gotoda et al., the criteria for undifferentiated-type EGC without lymph node 
metastasis was intramucosal cancer without ulceration and a diameter of no more than 
20mm (expanded-indication lesion). (Gotoda T et al.,2000) 
However, this category of tumor was diagnosed in only 141 cases, and the 95% confidence 
interval for the frequency of positive lymph node metastases was 0-2.6%. This corresponds 
to a 5-year survival rate worse than the 99% associated with surgically resected 
intramucosal gastric carcinoma. Therefore, expansion of the indications for ER to include 
undifferentiated-type EGC was not widely accepted at that time. 
Recently, Hirasawa et al. added to Gotoda’s findings, by reporting on cases of 
undifferentiated-type EGC resected at their institutions over the past 9 years; they reported 
the lymph node metastasis rate and the validity of ER for undifferentiated-type EGC. 
(Hirasawa T et al,.2009) In the study, the number of expanded-indication lesion reached 310, 
and no lymph node metastasis was found in any of these cases. (Table 1) 
 
 
Table 1. Lymph node metastasis by tumor size without UL and LVI in undifferentiated-type 
intramucosal EGC  LNM: lymph node metastasis   LVI: lymphatic-vascular capillary 
involvement   UL: ulcerative findings 
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Thus, the 95% confidence interval decreased to 0-0.96%, with an upper limit of 1% or less. 
Therefore, it is suggested that the expanded-indication lesion of undifferentiated-type EGC 
could be considered suitable for curative ER due to the negligible risk of lymph node 
metastasis. 
Several studies have proved that none of the cases of surgically resected expanded-
indication lesions was associated with positive lymph nodes. (Ha TK et al.,2008 ; Li C et 
al.,2008 ; Li H et al.,2008 ; Ye BD et al.,2008 ; Kunisaki C et al.,2009 ; Li H et al.,2010) 
However, even if the lesion met the criteria for expanded-indication lesion pathologically, 
in the previous study, some lesions with lymph node metastasis were reported. In three 
studies of surgically resected undifferentiated-type EGC that were 20mm or smaller in 
diameter and had neither ulceration nor lymphovascular invasion, a few were found to 
have metastasized. Lymph node metastases were found by Abe et al. in two cases with 10-
mm or 12-mm lesions, (Abe N et al.,2004) by Nasu et al. in one case with a 13-mm lesion, 
(Nasu J et al.,2006) and by Park et al. in one case with a 17-mm lesion. (Park YD et 
al.,2008) 
Even though the expanded-indication lesions of undifferentiated-type EGC have a very low 
risk of lymph node metastasis according to the report of Hirasawa et al, we should remain 
aware of the fact that a few of the expanded-indication lesion cases may have lymph node 
metastases. 
What kind of mechanism would permit such a lesion to metastasize to the lymph nodes?  
In normal gastric mucosa, lymphatic vessels are not found in the upper and middle part  
of the lamina propria; they exist in the deep lamina propria adjacent to the muscularis 
mucosa.     
These morphologic findings correlate with clinicopathological observations on early gastric 
cancer. The particularly low incidence of lymph node metastases in the subtype of early 
gastric cancer that remains confined to the mucosa may be explained by the rarity of lymph 
capillaries in the mucosa. (Lehnert T et al.,1985 ; Listrom MB et al.,1987) 
Sako et al. studied the distribution of lymphatic vessels in the gastric wall by 
immunostaining for D2-40. (Sako A et al., 2006) The densest distribution of lymphatic 
vessels was seen in the muscularis mucosa layer. If cancer cells reached the muscularis 
mucosa layer, they might have the greatest chance of invading the lymphatic vessels.  
The morphological detection of intralymphatic tumor cells might be more difficult in 
undifferentiated-type EGC than differentiated-type EGC. The reason for this was 
presumed to be that undifferentiated-type EGC are often associated with a loss of 
glandular formation in the gastric wall, and the cancer cells may be more scattered in the 
lymphatic vessels.     
Therefore, it is possible that if undifferentiated-type EGC reached the deep layer of the 
mucosa or the muscularis mucosa, the cancer cell could metastasize to the lymph node 
without invading the general lymphatic system. 
However, it is noteworthy that no case with expanded-indication lesions of 
undifferentiated-type EGC less than 10mm in diameter had lymph node metastases. ER is 
therefore indicated in such lesions.  
We suggest that ER should be used for the treatment of expanded-indication lesions of 
undifferentiated-type EGC in order to avoid unnecessary invasive surgery and optimize the 
quality of life. 
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3. The characteristics of expanded-indication lesion of undifferentiated-type 
EGC 
Most patients with EGC treatable using ER have presented with no cancer related symptom: 
they have undergone an endoscopy because of symptoms of gastritis or esophagitis, and the 
cancers have been diagnosed incidentally. 
Because an undifferentiated-type EGC indicated for ER has a diameter less than 20mm,  
it is important for an endoscopist to fully understand the endoscopic finding of such a 
lesion.  
We performed a retrospective analysis of 60 patients who had histologically expanded-
indication lesions of undifferentiated-type EGC in whom an ESD was performed at the 
Cancer Institute Hospital between March 2005 and August 2009. The patient characteristics 
and the endoscopic findings are shown in Table 2. 
 
 
Table 2. Patient characteristics (n=60) 
The mean age of the patients was 58.3±10.8 years (range, 33-81 years), and number of male 
and female patients was 24 (40%) and 36 (60%) respectively.  
The locations of lesions were as follows: lower third of stomach in 12 cases (20%); middle 
third in 45 cases (75%); upper third in 3 cases (5%).  
Regarding the gross type, 11 lesions (18%) were flat, and 49(82%) were depressed,  
and regarding the tumor color, 52 (87%) were discolored, and 8 (13%) were reddish. 
Twenty-eight lesions (47%) were less than 10mm in diameter, and 32(53%) were larger than 
10mm.    
Regarding the histological findings, 40(67%) were signet ring cell carcinoma, and 20(33%) 
were poorly-differentiated adenocarcinoma.  
Regarding the association between tumor size and histological finding, 22 of 28 lesions 
(79%) less than 10mm in diameter were histologically signet ring cell carcinoma, 18 of 32 
lesions (56%) greater than 10mm in diameter were poorly-differentiated adenocarcinoma; 
lesions greater than 10mm in diameter frequently showed poorly-differentiated 
adenocarcinoma.    
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With respect to Helicobacter pylori (HP) infection, 17 of 60 patients (17%) showed no HP 
infection and no atrophic change in the gastric mucosa, these 17 patients were negative for 
serum HP antibody and serum pepsinogen; undifferentiated-type EGC was found in the 
patients who were negative for HP infection.  
In summary, undifferentiated-type EGC tended to be found more frequently in females than 
in males, located in the middle third of the stomach, be ‘discolored’ in appearance, and was 
most frequently of the depressed type. (Fig 2) 
 
 
a: Routine observation: A discolored area with biopsy scar in the central was located on the lower-body 
lesser curvature.. (yellow arrows) 
b: Indigo carmine spraying: Dye spraying revealed a discolored lesion with depression. (yellow arrows). 
c: Narrow band imaging with magnifying view : NBI showed irregular vascular pattern in the depressed 
lesion. (yellow arrows) 
d: Resected specimen: specimen size 28×23 mm, tumor size 13×9 mm, type 0-IIc, sig, UL(-), pM, ly0, v0, 
LM(-), VM(-). 
e: HE staining: Tubular structure in the lesion was not recognized. 
f: PAS staining: Signet-ring cells with PAS staining positive were observed in the middle layer of the 
mucosa.(yellow arrows) 
Fig. 2. Undifferentiated EGC met expand-indication criteria for ESD. 
In the development of gastric cancer, it was very interesting that undifferentiated-type EGC 
was even found in the patients with no evidence of HP infection. (Fig 3)  
In a depressed-type EGC, encroachment of the border is one important malignant sign to 
look for in endoscopic findings. (Oohara et al.,1984 ; Fujii T et al.,1994) However, Takahashi 
et al. reported that encroachment of the border was found in only 20% patients with 
undifferentiated-type EGC with diameters less than 10mm. (Takahashi H et al.,2009) 
To diagnose undifferentiated-type EGC treatable by ER, an endoscopist should take care 
when performing an endoscopic examination in order not to overlook a depressed and 
discolored lesion with no encroachment of the border. 
www.intechopen.com
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a: Routine observation: A discolored area was located on the lower-body anterior wall. (yellow arrows) 
This patient had not H.pylori infection 
b: Closed view: The border of discolored area was clearly distinguished from the adjacent mucosa. 
c: Indigo carmine spraying: Dye spraying revealed a discolored lesion without depression. (yellow 
arrows). The macroscopic appearance suggested type 0-IIb early gastric cancer. 
d: Resected specimen: specimen size 28×23 mm, tumor size 13×9 mm(red line), type 0-IIc, sig, UL(-), pM, 
ly0, v0, LM(-), VM(-). 
e: HE staining: Tubular structure in the middle layer of the lesion was not recognized. 
f: PAS staining: Signet-ring cells with PAS staining positive were observed in the middle layer of the 
mucosa. (yellow arrows) 
Fig. 3. A case of undifferentiated EGC without H.pylori infection. 
4. Diagnosis of tumor margin and narrow band imaging for undifferentiated-
type EGC  
Narrow band imaging (NBI) is a new electronic endoscopy system ideally suited to the 
observation of surface structures, including capillaries. With NBI, short wavelength light 
radiated through a narrow band filter is strongly absorbed by hemoglobin, thereby allowing 
surface vascular structures to be distinctly visualized. (Gono K et al.,2004)    
The NBI-magnifying endoscopy is capable of predicting the histological characteristics of 
gastric cancer lesions in not only well-differentiated-type ECG but also in undifferentiated-
type. 
Nakayoshi et al. reported that microvascular structures can be observed using the NBI 
magnifying endoscopy, with a fine network pattern visible in well-differentiated-type EGC, 
and, in contrast, a corkscrew pattern in undifferentiated-type EGC. (Nakayoshi T et al.,2004)  
Taken together, these findings suggest that, if a discolored depressed lesion without 
encroachment found by conventional endoscopy showed a corkscrew pattern by NBI, the 
lesion is probably undifferentiated-type EGC. 
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It is well known that it is more difficult to determine the lesion margin in undifferentiated-
type EGC than in well-differentiated-type. In some cases of undifferentiated-type EGC, the 
lesion margin estimated macroscopically with the naked eye differs from that determined 
by pathology. (Ninomiya et al.,2000)     
This difference occurs when the tumor extends along the proliferative zone in the middle 
layer of the mucosa, leaving normal ducts covering the superficial mucosa. When this 
extension of cancer cells along the proliferative zone occurs, it is difficult to diagnosis the 
area of the lesion, even using NBI-magnifying endoscopy. To achieve a more accurate 
diagnosis, circumferential biopsies of the lesion should be done in all cases of 
undifferentiated-type EGC.     
Recently, we have reported that the width of the proliferative zone in 40 cases of expanded-
indication lesion of undifferentiated-type EGC ranged from 0 to 2,390μm (average 605.5μm). 
(Sawada S et al.,2010) (Fig.4) 
In no cases was the width of the proliferative zone over 3mm. (Table 3) 
From these results, we recommend that markings around a lesion should be placed 5mm 
beyond the endoscopically determined lesion margin, and mucosal incisions should be 
made outside these markings for ER of undifferentiated-type EGC. 
 
 
M : mucosa   MM : musucularis mucosa   SM : submucosa 
Fig. 4. Width of proliferative zone 
 
 
Table 3. Width of proliferative zone  (0-Ⅱc type undifferentiated-type intramucosal EGC) 
5. Therapeutic outcomes of ESD of undifferentiated-type EGC 
Endoscopic resections for EGD were divided into two types of procedures, endoscopic 
mucosal resection (EMR) and endoscopic submucosal dissection (ESD).  There are several 
EMR procedures, including the strip biopsy method (Okazaki Y et al.,1991), double channel 
method (Takekoshi T et al.,1986), EMR-cap method (Takeshita et al.,1997) These EMR 
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procedures, however, cannot be used for the en bloc resection of lesions larger than 2cm. 
(Hyun DH et al.,2003)   
On the other hand, ESD techniques can make en bloc resection of large lesions or ulcerated 
lesions feasible. It is important for the success of the ER of undifferentiated-type EGC that 
the histological findings are evaluated in detail. If the lesion is non-curative pathologically, 
the patient must undergo additional surgical resection of the stomach. Therefore, ER of 
undifferentiated-type EGC should be performed with an en bloc resection by ESD 
procedure.  
We reviewed 58 patients with preoperatively diagnosed undifferentiated-type  
EGC (expanded-indication lesion) who underwent ESD at the Cancer Institute Hospital 
between September 2003 and August 2008. 9 We carried out ESD using the insulation- 
tipped diathemic knife method, and glycerol or hyaluronic acid as the local injection 
material. 
The therapeutic outcomes of ESD are shown in Table 4.  
The mean diameter of resected specimens was 30mm (range, 15-48mm), the mean diameter 
of lesions was 11mm (range, 2-28mm), the median operation time was 70 min (range, 23-340 
min), the en bloc resection rate was 98 % (57/58 patients), the complete en bloc resection (R0 
resection) rate was 90 % (52/58 patients), the curative resection rate was 79 % (46/58 
patients). 
Bleeding complications occurred in five cases (8.6 %). No cases required blood transfusion 
or surgery. Perforation occurred in two cases (3.4%), both of which were conservatively and 
successfully treated by clipping closure. The mean hospital stay was 6.7 days (range, 4-14 
days) 
 
 
Table 4. ESD for undifferentiated-type EGC  treatment results  (N=58) 
Pathological examination revealed that expanded-indication lesions were present in 47 cases 
and non-indication lesions in 11. The therapeutic outcomes were compared between the two 
groups, as shown in Table 5.  
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Table 5. ESD for undifferentiated type EGC treatment results by lesion group (N=58) 
With the limited expanded-indication lesions, the mean diameter of the resected specimens 
was 29mm (range, 15-48mm), the mean diameter of lesions was 8.9mm (range, 2-18mm), the 
median operation time was 65 min (range, 23-340 min), the en bloc resection rate was 100 % 
(47/47 patients), the complete en bloc resection rate was 98 % (46/47 patients), and the 
curative resection rate was 98 % (46/47 patients). 
From these results, it can be seen that ESD of expanded-indication lesions for 
undifferentiated-type EGC was associated with good therapeutic outcomes. 
However, non-curative resection was pathologically identified in 12 (21%) of the 58 patients. 
Eleven of the 12 non-curative resection cases had non-indication lesions. The reasons for 
incurability were the presence of submucosal invasion in seven cases (12 % of 58 patients), 
tumor diameter of 21mm or more in five (8.6%), and the presence of ulcer scarring in two 
(3.4 %); some cases had more than one reason.  
The most common factor responsible for non-curative resection was incorrect diagnosis of 
the depth of invasion. (Table 6)  
 
 
Table 6. Factors responsible for non-curative resection of non-indication lesions (N=11)* 
Six of the seven patients who were found to have submucosal invasion had undergone EUS 
that resulted in a diagnosis of intramucosal carcinoma.  
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It has been reported previously that EUS correctly diagnosed the depth of invasion of EGC 
in 64-78% of cases, and the correct diagnosis rate was lower in cases of undifferentiated-type 
compared to differentiated-type. (Akahoshi K et al.,1998 ; Hizawa K et al.,2002) Although 
more accurate diagnosis of the invasive depth is necessary, the currently available 
assessment methods have limitations in their precision. (Kim JH et al.,2007) 
In terms of the technological aspects of ESD, resectable expanded-indication lesions of 
undifferentiated-type EGC are less than 20mm in diameter and have no ulceration, the ESD 
procedures are easier than for lesions with diameters greater than 20mm or for ulcerated 
differentiated-type EGC. Therefore, we consider that the ideal method for diagnosing the 
invasion depth might be to first carry out ESD followed by pathological examination of 
resected specimens.  
However, if this diagnostic ESD determines that a tumor diameter exceeds 20mm, it is 
probable that ESD will result in non-curative resection, so more precise preoperative 
diagnosis of the lesion area using circumferential biopsies is essential. 
6. Conclusion  
Endoscopic resection of differentiated-type EGC is now standard treatment not only in 
Japan but also in other parts of the world. Undifferentiated-type EGC has a high rate of 
lymph node metastasis compared with differentiated-type EGC, and endoscopic resection of 
undifferentiated-type EGC remains controversial.  
However, if the tumor is detected at an early stage and meets the criteria for expanded-
indication lesion of undifferentiated-type EGC, then the lymph node metastasis is very rare.  
We propose that endoscopic resection should be performed on such lesions to avoid 
unnecessary invasive surgery and optimize the quality of life. In this review, we have 
described our therapeutic outcomes of endoscopic resection for undifferentiated-type EGC.   
An interesting result amongst our cases was the observation that some patients who were H. 
pylori negative had undifferentiated-type EGC. The rate of H. pylori infection is predicted 
to decrease in the future. We should take care in the management of cases of 
undifferentiated-type EGC without H. pylori infection.  
It is necessary to study further cases, with a longer follow up period, to prove the validity of 
the concept of endoscopic resection of undifferentiated-EGC which we have proposed here.  
We hope that multicenter, prospective studies will be carried out to asses further this 
expanded-indication for ER of undifferentiated-type EGC.  
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certainly be more therapeutic. It started with endoscopic hemostasis and polipectomy, than beginning of the
1970's with the advent of endoscopic sphincterotomy extended to biliopancreatic pathology and has a huge
impact in this difficult pathology. Plastic stents made the first steps in endoscopic palliation of neoplastic
jaundice, metallic stents, covered or uncovered are better for biliary palliation and can be used also for
palliation neoplastic obstruction at different levels of the digestive tube. Resection of digestive tumors has
evolved now to sub-mucosal resection, looking to have one-piece complete resection. Interventional
endoscopy is now very complex and takes a lot of time for endoscopists to learn properly these techniques.
This book is a very good up-to-date overview of new techniques of interventional endoscopy for those who
want to learn or develop their knowledges in this field.
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